Corneal Endothelial Assessment After Posterior Chamber Phakic Intraocular Lens Implantation
Not Applicable
Recruiting
- Conditions
- Corneal Endothelial Cells
- Registration Number
- NCT06849375
- Lead Sponsor
- Sohag University
- Brief Summary
our primary aim of the work to assess the effect of phakic IOL implantation on corneal endothelium. we also used the specular microscope to assess the corneal endothelium
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Our inclusion criteria include: adults 18-35 years of age, myopia ˃ 6 D , anterior chamber depth (ACD) 2.85 mm or greater , an endothelial cell count of ≥ 2000 cells/mm2 and stable refractive history within 0.5 diopter for 1 year.
Exclusion Criteria
- anterior chamber depth from endothelium < 2.85 mm, previous or current systemic or eye disease , surgery or trauma, pregnancy and nursing.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method corneal endothelial cells assessment 1 year specular micrioscopy examination before and after phakic IOL implantation
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does posterior chamber phakic IOL implantation affect corneal endothelial cell density and morphology over time?
What are the comparative outcomes of posterior chamber phakic IOL versus anterior chamber phakic IOL on endothelial health using specular microscopy?
Which preoperative biomarkers correlate with postoperative endothelial cell loss after pIOL implantation in high myopia patients?
What adverse events are associated with corneal endothelial dysfunction following posterior chamber phakic IOL implantation and their management?
Are there alternative intraocular lens designs or adjunctive therapies that reduce endothelial cell loss compared to posterior chamber phakic IOLs?
Trial Locations
- Locations (1)
Sohag University Hospital
🇪🇬Sohag, Egypt